May 22, 2026 Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer
May 22, 2026 Yimutian’s WolaiCai AI Agent Goes Live Across All Platforms: 200 Million Daily Token Consumption, Agricultural AI Revenue Exceeds US$3,000 Per Day
May 22, 2026 STARTRADER CEO Peter Karsten Hosts University of Europe Sessions on AI, Operations, and Market Risk
